INSPIRE MEDICAL SYSTEMS Appoints Intuitive Surgical CMO to Board of Directors
December 30, 2023
☀️Trending News
INSPIRE MEDICAL SYSTEMS ($NYSE:INSP), a medical technology company specializing in the manufacturing of implantable neurostimulation systems, has recently appointed the Chief Medical Officer (CMO) of Intuitive Surgical to their Board of Directors. Intuitive Surgical is a global leader in robotic-assisted, minimally invasive surgeries. Its primary focus is on providing innovative solutions for patients with Obstructive Sleep Apnea (OSA). It has developed an implantable neurostimulation system that provides relief to those suffering from OSA by improving airway muscle activity during sleep.
The company has seen tremendous success in the medical industry due to its innovative and effective product offerings. His expertise and experience in the medical industry will be a valuable asset as INSPIRE MEDICAL SYSTEMS continues to expand and develop new solutions for its customers. This partnership will help INSPIRE MEDICAL SYSTEMS stay ahead of the curve in the medical technology field.
Market Price
On Friday, INSPIRE MEDICAL SYSTEMS announced that it had appointed Katherine VanValkenburg, the Chief Medical Officer of Intuitive Surgical, to its Board of Directors. This strategic move comes amid a steady growth in INSPIRE MEDICAL SYSTEMS’s stock prices. On the same day, it opened at $202.5 and closed at $203.4, a slight decrease of 0.2% from its previous closing price of 203.8. The company hopes that VanValkenburg’s industry expertise and healthcare leadership will help to strengthen the company’s current and prospective operations. Live Quote…
About the Company
Income Snapshot
Below shows the total revenue, net income and net margin for INSP. More…
| Total Revenues | Net Income | Net Margin |
| 570.19 | -32.77 | -5.7% |
Cash Flow Snapshot
Below shows the cash from operations, investing and financing for INSP. More…
| Operations | Investing | Financing |
| 26.66 | -146.05 | 31.35 |
Balance Sheet Snapshot
Below shows the total assets, liabilities and book value per share for INSP. More…
| Total Assets | Total Liabilities | Book Value Per Share |
| 639.49 | 95.31 | 18.43 |
Key Ratios Snapshot
Some of the financial key ratios for INSP are shown below. More…
| 3Y Rev Growth | 3Y Operating Profit Growth | Operating Margin |
| 80.9% | – | -5.6% |
| FCF Margin | ROE | ROA |
| 1.4% | -3.7% | -3.1% |
Analysis
At GoodWhale, we analyzed INSPIRE MEDIAL SYSTEMS’s financials and believe that it has an intermediate health score of 5/10, which indicates that it is likely to sustain future operations in times of crisis. INSPIRE MEDICAL SYSTEMS is classified as a ‘cheetah’, a type of company that has achieved high revenue or earnings growth but is considered less stable due to lower profitability. For investors considering investing in INSPIRE MEDICAL SYSTEMS, it is important to note that the company is strong in asset and growth, but weak in dividend and profitability. This makes it ideal for investors who are looking for higher-risk/higher-reward opportunities but are not expecting a steady stream of dividends. For those looking for a more stable investment opportunity, it may be wise to look elsewhere. More…
Peers
The company’s competitors include ShockWave Medical Inc, InMode Ltd, and INVO Bioscience Inc.
– ShockWave Medical Inc ($NASDAQ:SWAV)
ShockWave Medical Inc is a medical device company that uses shockwave technology to treat cardiovascular disease. The company has a market cap of 9.73B as of 2022 and a return on equity of 19.56%. The company’s products are used to treat a variety of cardiovascular diseases, including coronary artery disease, peripheral artery disease, and heart failure.
– InMode Ltd ($NASDAQ:INMD)
InMode Ltd is a medical technology company that develops and manufactures minimally invasive aesthetic solutions. The company has a market capitalization of $2.71 billion as of 2022 and a return on equity of 41.58%. InMode’s products are used by physicians and patients in over 90 countries and the company has a strong presence in the United States, Europe, Asia, and Latin America. InMode’s products are backed by clinical research and have been featured in numerous peer-reviewed journals.
– INVO Bioscience Inc ($NASDAQ:INVO)
INVO Bioscience Inc is a medical device company that has developed a patented in vivo intravaginal culture (IVC) system, which is used to treat infertility. The company’s IVC system is designed to provide a more natural environment for embryo development and is intended to improve the success rates of in vitro fertilization (IVF). INVO Bioscience’s IVC system is currently being used at fertility clinics in the United States and Europe.
Summary
Inspire Medical Systems is a medical technology company focused on the treatment of obstructive sleep apnea. It offers an implantable device that provides stimulation to key airway muscles, helping to open the airway to provide effective relief from sleep apnea. The company recently announced the appointment of Intuitive Surgical’s Chief Marketing Officer (CMO), Karan Arora, to its Board of Directors.
This expands the depth of expertise on the board as Arora brings extensive experience in areas such as commercial operations, marketing and business strategy. Investors should watch for any updates from the company regarding its clinical trials, potential approvals, and commercialization of its device, as these events could lead to positive share price movement.
Related Posts
Recent Posts
Investing Everyone Can Do.
Investing shouldn’t be exclusive to a select few. We believe everyone should have the opportunity to grow their wealth. That’s why our app is designed to be accessible and user-friendly, even for beginners.
